Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Colorcon
Harvard Business School
Medtronic
McKesson

Last Updated: June 29, 2022

Wyeth Ayerst Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WYETH AYERST, and what generic and branded alternatives to WYETH AYERST drugs are available?

WYETH AYERST has eighty-two approved drugs.



Summary for Wyeth Ayerst
US Patents:0
Tradenames:64
Ingredients:56
NDAs:82

Drugs and US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst NALOXONE naloxone hydrochloride INJECTABLE;INJECTION 070190-001 Sep 24, 1986 DISCN No No See Plans and Pricing See Plans and Pricing
Wyeth Ayerst UNIPEN IN PLASTIC CONTAINER nafcillin sodium INJECTABLE;INJECTION 050320-002 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing
Wyeth Ayerst DIUCARDIN hydroflumethiazide TABLET;ORAL 083383-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Wyeth Ayerst GRISACTIN griseofulvin, microcrystalline TABLET;ORAL 060212-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Wyeth Ayerst SPARINE promazine hydrochloride SYRUP;ORAL 010942-003 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-002 Sep 7, 1982 3,658,993 See Plans and Pricing
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-003 Sep 7, 1982 3,658,993 See Plans and Pricing
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-001 Jul 31, 1987 3,641,127 See Plans and Pricing
Wyeth Ayerst PMB 200 estrogens, conjugated; meprobamate TABLET;ORAL 010971-005 Approved Prior to Jan 1, 1982 5,210,081 See Plans and Pricing
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-003 Jan 9, 1986 3,641,127 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Moodys
Colorcon
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.